May 7, 2026 InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren’s Syndrome in China
May 7, 2026 Chance Pharma Announces NMPA Acceptance of New Drug Application for Investigational Respiratory Drug CXG87
May 7, 2026 V2X, INC. ANNOUNCES PRICING OF OFFERING OF APPROXIMATELY 2.0 MILLION SHARES OF COMMON STOCK IN SECONDARY OFFERING BY VERTEX AEROSPACE
